Ephedrine controls heart rhythms by activating cardiac Iks currents

Journal of Cardiovascular Pharmacology

Volumn 55, Issue 2, 2010, Pages 145-152

  Jing, Hongjuan ^a   Luo, Lan ^a   Li, Hui ^a   Sun, Jing ^a   Yi, Hong ^b   Wu, Yingliang ^b   Wang, Changdong ^a   He, Guangyuan ^a  

^a HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

^b WUHAN UNIVERSITY   (China)

Author keywords

Ephedrine; KCNQ1 channel; LQTS; Pseudoephedrine

Indexed keywords

EPHEDRINE; POTASSIUM CHANNEL KCNE1; POTASSIUM CHANNEL KCNQ1; POTASSIUM CHANNEL KCNQ2; POTASSIUM CHANNEL KCNQ3; PSEUDOEPHEDRINE; KCNE1 PROTEIN, MOUSE; POTASSIUM CHANNEL PROTEIN I(SK); VOLTAGE GATED POTASSIUM CHANNEL;

ANIMAL EXPERIMENT; ARTICLE; CELL STRAIN HEK293; CONTROLLED STUDY; DOSE RESPONSE; DRUG PROTEIN BINDING; HEART RATE; HEART RHYTHM; HUMAN; HUMAN CELL; MALE; MOUSE; NONHUMAN; POTASSIUM CURRENT; PRIORITY JOURNAL; QT INTERVAL; AMINO ACID SEQUENCE; ANIMAL; BAGG ALBINO MOUSE; CELL LINE; CHEMISTRY; COMPARATIVE STUDY; DRUG EFFECTS; LONG QT SYNDROME; METABOLISM; MOLECULAR GENETICS; PATHOPHYSIOLOGY; PHYSIOLOGY;

AMINO ACID SEQUENCE; ANIMALS; CELL LINE; EPHEDRINE; HEART RATE; HUMANS; KCNQ1 POTASSIUM CHANNEL; LONG QT SYNDROME; MALE; MICE; MICE, INBRED BALB C; MOLECULAR SEQUENCE DATA; POTASSIUM CHANNELS, VOLTAGE-GATED;

EID: 77649277762     PISSN: 01602446     EISSN: None     Source Type: Journal    
DOI: 10.1097/FJC.0b013e3181ce965c     Document Type: Article

References (34)

1. Kalix P. The pharmacology of psychoactive alkaloids from ephedra and catha. J Ethnopharmacol. 1991;32:201-208.
2. Arch JR, Ainsworth AT, Cawthorne MA, et al. A typical-adrenoceptor on brown adipocytes as target for antiobesity drugs. Nature. 1984;309: 163-165.
3. Liu YL, Toubro S, Astrup A, et al. Contribution of beta 3-adrenergic activation to ephedrine-induced thermogenesis in humans. Int J Obes relat metab Disord. 1995;19:678-685.
4. Wang Q, Curran ME, Splawski I, et al. Positional cloning of a novel potassium channel gene: KVLQT1 mutations cause cardiac arrhythmias. Nat Genet. 1996;12:17-23.
5. Jentsch TJ. Neuronal KCNQ potassium channels: physiology and role in disease. Nat Rev Neurosci. 2000;1:21-30.
6. Jespersen T, Grunnet M, Olesen SP. The KCNQ1 potassium channel: from gene to physiological function. Physiology (Bethesda). 2005;20:408-416.
7. Geoffrey WA, Steve ANG. Potassium channel subunits encoded by the KCNE gene family: physiology and pathophysiology of the MinKRelated peptides (MiRPs). Mol interv. 2001;1:95-107.
8. Barhanin J, Lesage F, Guillemare E, et al. K(v)LQT1 and IsK (minK) proteins associate to form the IKs cardiac potassium current. Nature. 1996; 384:78-80.
9. SanguinettiMC,CurranME,ZouA, et al.CoassemblyofK(v)LQT1andminK (IsK)proteins toformcardiac IKs potassium channel. Nature. 1996;384:80-83.
10. Kass RS, Moss AJ. Long QT syndrome: novel insights into the mechanisms of cardiac arrhythmias. J Clin Invest. 2003;112:810-815.
11. Keating MT, Sanguinetti MC. Molecular and cellular mechanisms of cardiac arrhythmias. Cell. 2001;104:569-580.
12. Karen M,William RK. Discovery of a novel activator of KCNQ1-KCNE1 K+ channel complexes. PLoS ONE. 2009;4:1-9.
13. GaoZ,XiongQ,SunH,etal. Desensitizationofchemicalactivationbyauxiliary subunits: convergence of molecular determinants critical for augmenting KCNQ1 potassium channels. J Biol Chem. 2008;283:22649-22658.
14. Salata JJ, Jurkiewicz NK, Wang JX, et al. A novel benzodiazepine that activates cardiac slow delayed rectifier K+ Currents. Mol Pharmacol. 1998;53:220-230.
15. Seebohm G, Pusch M, Chen J, et al. Pharmacological activation of normal and arrhythmia-associated mutant KCNQ1 potassium channels. Circ Res. 2003;93:941-947.
16. Wang HS, Pan ZM, Shi WM, et al. KCNQ2 and KCNQ3 potassium channel subunits: molecular correlates of the M-channel. Science. 1998; 282:1890-1893.
17. Wickenden AD, Yu W, Zou A, et al. Retigabine, a novel anti-convulsant, enhances activation of KCNQ2/Q3 potassium channel. Mol Pharmacol. 2000;58:591-600.
18. Howden R, Hanlon PR, Petranka JG, et al. Ephedrine plus caffeine causes age-dependent cardiovascular responses in Fischer 344 rats. Am J Physiol Heart Circ Physiol. 2005;288:H2219-H2224.
19. Kobayashi S, Endou M, Sakuraya F, et al. The sympathomimetic actions of l-ephedrine and d-pseudoephedrine: direct receptor activation or norepinephrine release? Anesth Analg. 2003;97:1239-1245.
20. Yao J, Chen X, Li H, et al. BmP09, a "long chain" scorpion peptide blocker of BK channels. J Biol Chem. 2005;280:14819-14828.
21. Li H, Yao J, Tong XT, et al. Interaction sites between the Slo1 pore and the NH2 terminus of the b2 subunit, probed with a three-residue sensor. J Biol Chem. 2007;282:17720-17728.
22. McMahon LR, Cunningham KA. Discriminative stimulus effects of (-)- ephedrine in rats: analysis with catecholamine transporter and receptor ligands. Drug Alcohol Depend. 2003;70:255-264.
23. Salata JJ, Jurkiewicz NK, Jow B, et al. IK of rabbit ventricle is composed of two currents: evidence for IKs. Am J Physiol. 1996;271:H2477-H2489.
24. Xiong QJ, Sun HY, Zhang YM, et al. Combinatoral augmentation of voltage-gated KCNQ potassium channels by chemical openers. Proc Natl Acad Sci USA. 2008;105:3128-3133.
25. Schroder RL, Jerspersen T, Christophersen P, et al. KCNQ4 channel activation by BMS-204352 and retigabine. Neuropharmacology. 2001;40: 888-898.
26. Doyle DA, Cabral JM, Pfuetzner RA, et al. The Structure of the potassium channel: molecular basis of K+ conduction and selectivity. Science. 1998; 280:69-77.
27. Reopke TK, Abbott GW. Pharmacogenetics and cardiac ion channels. Vascul Pharmacol. 2006;44:90-106.
28. Varró A, Baláti B, Iost N, et al. The role of the delayed rectifier component IKs in dog ventricular muscle and Purkinje fibre repolarization. J Physiol. 2000;523:67-81.
29. Lengyel CS, Iost N, Virág L, et al. Pharmacological block of the slow component of the outward delayed rectifier current (IKs) fails to lengthen rabbit ventricular muscle QTc and action potential duration. Br J Pharmacol. 2001;132:101-110.
30. Jost N, Virág L, Bitay M, et al. Restricting excessive cardiac action potential and QT prolongation-a vital role for Iks in human ventricular muscle. Circulation. 2005;112:1392-1399.
31. Roden DM, Lazzara R, Rosen M, et al; for the SADS Foundation Task Force on LQTS. Multiple mechanisms in the long QT syndrome: current knowledge, gaps, and future directions. Circulation. 1996;94:1996-2012.
32. Persky AM, Berry NS, Pollack GM, et al. Modelling the cardiovascular effects of ephedrine. Br J Clin Pharmacol. 2004;57:552-562.
33. Kurokawa J, Chen L, Kass RS. Requirement of subunit expression for cAMP-mediated regulation of a heart potassium channel. Proc Natl Acad Sci USA. 2003;100:2122-2127.
34. Sanguinetti MC, Jurkiewicz NK, Scott A, et al. Isoproterenol antagonizes prolongation of refractory period by the class III antiarrhythmic agent E- 4031 in guinea pig myocytes: mechanism of action. Circ Res. 1991;68: 77-84.